Vitamin D Treatment in Patients With Chronic Hepatitis C

Not Applicable

• Conditions: Chronic Hepatitis C
• Interventions: Drug: Adding vitamin D; Drug: Vitamin D

• Registration Number: NCT00804752
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-12
• Study First Submitted: 2008-12-07
• Study First Submitted QC: 2008-12-08
• Last Update Submitted: 2008-12-08
• Study First Posted: 2008-12-09
• Last Update Posted: 2008-12-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Chronic Hepatitis C Genotype 1

Exclusion Criteria

• Vitamin D intoxication Renal Failure Liver Failure Malignancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Vitamin D	Adding vitamin D	An addition of Vitamin D to the standard treatment
Vitamin D	Vitamin D	An addition of Vitamin D to the standard treatment

Primary Outcome Measures

Name	Time	Method
To increase the sustained virological response	One year

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel